EV450 Anti-Human CD62L Antibody[DREG56]

The EV450 Anti-Human CD62L Antibody[DREG56] is a highly specific and sensitive monoclonal antibody that has been designed for use in a variety of research applications. This antibody is specifically targeted against the human CD62L protein, which is a cell surface receptor that is expressed on a variety of leukocytes, including T cells, B cells, and natural killer cells.

The EV450 Anti-Human CD62L Antibody[DREG56] has been extensively validated for use in flow cytometry, immunohistochemistry, and other immunological assays. It has been shown to be highly effective in detecting and quantifying CD62L expression on a variety of cell types, and it has been used in numerous studies to investigate the role of CD62L in immune cell function and disease.

This antibody is produced using state-of-the-art techniques and is rigorously tested to ensure its purity, specificity, and activity. It is supplied in a convenient format that is ready-to-use and can be easily incorporated into a variety of experimental protocols.

Overall, the EV450 Anti-Human CD62L Antibody[DREG56] is a highly reliable and effective tool for investigating the role of CD62L in immune cell function and disease. Its high specificity and sensitivity make it an ideal choice for researchers working in the fields of immunology, cell biology, and molecular biology.